Amarin Corp Plc (AMRN)

[ilovetech]

I think it's time to change course. Amarin has to sell Gv into Marine and Branded V for Reduce-it. Amarin won't launch until Geneneric's have launched. If Generics follow through, Amarin will adjust and maintain any price Generics set. In the meantime, Generics will have to go through a development process to launch a pill that rises to the same standard as Amarin's. Can Generics pull that off? Will they stay in the market without having a price advantage to divert sales? If yes, how much sales to Justify production? Pharmacies will have no incentive to fill Generics product while Amarin's Gv is available.

We continue to build the Vascepa brand while continuing to build sales abroad.

ILT